Jitong Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jitong Zhou has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Hayday
Francis Crick Institute, London, UK
1 shared publication - Annabel Borg
The Francis Crick Institute, London, UK
1 shared publication - Antonia Landwehr
School of Medical Sciences, Faculty of Health University of Victoria Victoria British Columbia Canada
1 shared publication - Carola G. Vinuesa
Francis Crick Institute, London, UK
1 shared publication - Fernanda Teixeira Subtil
Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute
1 shared publication - Harriet Feldman
Francis Crick Institute, London, UK
1 shared publication
Latest Publications
- Open Access
The antipsychotic drug clozapine suppresses autoimmunity driving psychosis-like behavior in mice
Antipsychotic drugs are the first-line treatment for psychosis yet their mechanism of action remains poorly understood, largely due to the challenge to faithfully model psychosis preclinically. Here, we focus on the emerging concept that psychosis can be caused by brain autoimmunity and present a novel mouse model of anti-N-methyl-D-aspartate-receptor (anti-NMDAR) encephalitis, a condition that manifests with psychosis and autoantibodies against the NMDAR. We devised a new mRNA-based approach to immunize mice against the NMDAR. Immunized mice developed psychosis-like behaviors that were caused by anti-NMDAR autoantibodies leading to phagocytosis of NMDARs by brain micro-glia. The antipsychotic drug clozapine rescued psychosis-like behaviors and, remarkably, reduced anti-NMDAR autoantibody levels and antibody-mediated phagocytosis of NMDARs. The immunomodulato-ry effects of clozapine were confirmed in a mouse model of systemic lupus erythematosus. Our results demonstrate that clozapine suppresses autoimmunity driving psychosis-like behaviors, raising the possibility that immunomodulation contributes to antipsychotic drug action.
Open AccessThe antipsychotic drug clozapine suppresses autoimmunity driving psychosis-like behavior in mice
Antipsychotic drugs are the first-line treatment for psychosis yet their mechanism of action remains poorly understood, largely due to the challenge to faithfully model psychosis preclinically. Here, we focus on the emerging concept that psychosis can be caused by brain autoimmunity and present a novel mouse model of anti-N-methyl-D-aspartate-receptor (anti-NMDAR) encephalitis, a condition that manifests with psychosis and autoantibodies against the NMDAR. We devised a new mRNA-based approach to immunize mice against the NMDAR. Immunized mice developed psychosis-like behaviors that were caused by anti-NMDAR autoantibodies leading to phagocytosis of NMDARs by brain micro-glia. The antipsychotic drug clozapine rescued psychosis-like behaviors and, remarkably, reduced anti-NMDAR autoantibody levels and antibody-mediated phagocytosis of NMDARs. The immunomodulato-ry effects of clozapine were confirmed in a mouse model of systemic lupus erythematosus. Our results demonstrate that clozapine suppresses autoimmunity driving psychosis-like behaviors, raising the possibility that immunomodulation contributes to antipsychotic drug action.